Neurowyzr's Innovative DBFS Tool Revolutionizes Early Detection of Neurodegenerative Diseases
Neurowyzr, a Singapore-based startup, has made waves in the digital health sector with its innovative Digital Brain Function Screen (DBFS). This web-based tool, designed for early detection of neurodegenerative diseases, has received positive feedback from healthcare practitioners and users alike. The DBFS has undergone rigorous clinical validation and is now registered with Singapore's HSA, the US FDA, and Australia's TGA as a digital medical device.
Nav Vij, the founder of Neurowyzr, was inspired to create the DBFS after witnessing a family member's struggle with a neurodegenerative disease. Joined by CEO Pang Sze Yunn, who has experience in digital health and understands the challenges faced by caregivers, the duo set out to make brain health assessment more accessible and affordable.
The DBFS is a gamified neuroscience puzzle assessment that is more affordable and accessible than traditional testing methods. It costs 8-10 times less and does not require neurospecialists or specialized equipment. The tool has been designed to be scalable and accessible across geographies, languages, and cultures, with highly visual tests that minimize language barriers.
The response to the DBFS has been positive. Healthcare practitioners find it easy to adopt and implement, while users feel reassured by the results and educated by the accompanying report. Early detection is crucial for neurodegenerative diseases, which often progress silently before manifesting with tangible symptoms. Traditional pen and paper tests are inefficient and biased, while alternative methods like MRI or CT scans are expensive.
Neurowyzr's future expansion plans include partnering with more clinics, GPs, and healthcare providers in Singapore, India, Asia, and the US. They also aim to develop a full suite of digital brain health solutions.
With its innovative DBFS tool, Neurowyzr is democratizing access to brain health assessments. The tool's affordability, accessibility, and ease of use make it a promising solution for early detection of neurodegenerative diseases. As the company continues to expand its reach and develop new solutions, it is poised to make a significant impact on the digital health landscape.
